FAIRFIELD-SUISUN, CALIFORNIA
San Diego’s Carlsmed corrals $10 million to bring personalized medicine to spine surgeries [The San Diego Union-Tribune]
San Diego’s Carlsmed, which received regulatory approval last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding.
The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S.
Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data and other information to design personalized implants for surgeries to straighten the spine, said Mike Cordonnier, chief executive and co-founder of Carlsmed.
Daily Business Report-Dec 17, 2020, San Diego Metro Magazine sandiegometro.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegometro.com Daily Mail and Mail on Sunday newspapers.
Print
San Diego’s Carlsmed, which received regulatory clearance last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding.
The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S.
Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data and other information to design personalized implants for surgeries to straighten the spine, said Mike Cordonnier, chief executive and co-founder of Carlsmed.
socaltech.com
San Diego-based
Carlsmed, a biotech startup developing spine deformity correction devices, has raised $10M in a Series A funding. The funding was led by U.S. Venture Partners, and also included The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. According to the company, the funding will go to commercialize the company s family of aprevo spine deformity correction devices. The startup is led by CEO Mike Cordonnier. As part of the funding, it has added USVP s Jonathan Root, USVP s Phil Young, and Kevin Sidow, past CEO of St. Francis Medical Technologies and Moximed, to its board of directors.